These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4026487)

  • 1. Simple method for maintaining serum lidocaine levels in the therapeutic range.
    Wong BY; Hurwitz A
    Arch Intern Med; 1985 Sep; 145(9):1588-91. PubMed ID: 4026487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS; Boersma RB
    Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effectiveness of lidocaine in patients with ventricular arrhythmias estimated relative to measurements of drug concentration in serum].
    Sinkiewicz W; Marzec A; Hoffman A; Jankowski A; Bartuzi Z; Romański B
    Kardiol Pol; 1989; 32(7-9):366-71. PubMed ID: 2639975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma level of lidocaine following intraoperative bolus injection and infusion in heart failure].
    Biscoping J; von Bormann B; Boldt J; Kling D; Hempelmann G
    Anasth Intensivther Notfallmed; 1984 Oct; 19(5):250-2. PubMed ID: 6335002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of lidocaine after intramuscular injection and subsequent infusion in patients with acute myocardial infarction.
    Oltmanns D; Lübben C; Pentz R; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):582-4. PubMed ID: 7152740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Slower lidocaine elimination and dose adjustment in patients with heart failure].
    Follath F; Ritz R; Vozeh S; Wenk M
    Schweiz Med Wochenschr; 1982 May; 112(22):789-91. PubMed ID: 6808662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study for validation of Bayesian prediction approach to adjust individual lidocaine dosage.
    Uematsu T; Hirayama H; Umemura K; Kosuge K; Nakashima M
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):33-7. PubMed ID: 8199750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of intramuscular lidocaine in the acute stage of myocardial infarction].
    Djiane P; Egre A; Perchicot B; Bory M; Serradimigni A; Bruguerolle B; Bouyard P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):931-8. PubMed ID: 6793010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention, clinical aspects and therapy of the side-effects of lidocaine].
    Kettner W; Lenz M; Kettner E; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Oct; 39(20):501-5. PubMed ID: 6516492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimum dosage of lidocaine.
    Laurikainen E; Arstila M; Pekkarinen A; Kanto J
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):16-9. PubMed ID: 3988388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic lidocaine hydrochloride does not reduce ventricular arrhythmias after coronary artery bypass grafting in patients with poor left ventricular function.
    Juneja R; Mehta Y; Trehan N
    Indian Heart J; 1993; 45(6):483-7. PubMed ID: 8070826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
    Sawyer DR; Ludden TM; Crawford MH
    Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of lidocaine after intramuscular injection in patients with acute myocardial infarction (author's transl)].
    Oltmanns D; Siegers CP
    Z Kardiol; 1979 Mar; 68(3):131-6. PubMed ID: 442753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies on dose adjustment of intraoperative lidocaine therapy in heart failure patients].
    Biscoping J; Kling D; von Bormann B; Hehrlein F; Hempelmann G
    Anasth Intensivther Notfallmed; 1985 Jun; 20(3):136-8. PubMed ID: 4037261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated administration of lidocaine for the treatment of ventricular arrhythmias.
    Jannett TC; Kay GN; Sheppard LC
    Med Prog Technol; 1990 May; 16(1-2):53-9. PubMed ID: 1690837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
    Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
    Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum concentration measurements for the monitoring of anti-arrhythmic therapy with lidocaine].
    Follath F; Heierli B; Ganzinger U; Wenk M
    Schweiz Med Wochenschr; 1980 Jun; 110(26):1007-10. PubMed ID: 6158756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lidocaine and procainamide toxicity during treatment of ventricular arrhythmias.
    Mattea J; Mattea E
    Am J Nurs; 1976 Sep; 76(9):1429-31. PubMed ID: 1048862
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood levels of lidocaine after various infusion rates in patients with acute myocardial infarction.
    Rydén L; Waldenström A; Winsnes Y; Ortengren B
    Am Heart J; 1975 Apr; 89(4):470-3. PubMed ID: 1114978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.